Gene therapy pioneer Shiela Mikhail is stepping down as CEO at AskBio
Sheila Mikhail, a pioneer and thought leader in genetics, is stepping down as CEO of AskBio, a company she co-founded and later sold to global giant Bayer AG.
Read MorePosted by WRAL TechWire | Mar 9, 2023
Sheila Mikhail, a pioneer and thought leader in genetics, is stepping down as CEO of AskBio, a company she co-founded and later sold to global giant Bayer AG.
Read MorePosted by WRAL TechWire | Jan 23, 2023
Imagine receiving a COVID-19 vaccine not from the jab of a needle and syringe but by slipping a thin, clear film smaller than a postage stamp inside your cheek or under your tongue and letting it dissolve. That’s one of the potential benefits of a new drug-delivery technology being developed by a startup company in Chapel Hill.
Read MorePosted by WRAL TechWire | Mar 8, 2022
Seventeen months after negotiating a whopping $4 billion buyout deal with German pharma giant Bayer, Asklepios BioPharmaceutical (AskBio) CEO and co-founder Sheila Mikhail says the pioneering gene therapy company is hitting all its targets. And she continues to wage her own battle with lupus.
Read MorePosted by WRAL News | Oct 28, 2020
After sale to Bayer, gene therapy firm AskBio plans expansion and hiring, says its CEO in an exclusive interview with WRAL TechWire.
Read More